2017-10-11 19:20:44 UTC

Duration of Hepatitis C Virus Therapy

Oct. 11, 2017

Shorter duration therapy reduces treatment costs and may also improve adherence. How short can therapy be and who would qualify?

Guidelines for the treatment of chronic hepatitis C virus (HCV) do not encourage treatment for less than 12 weeks. Benjamin Emmanuel, MPH, Eleanor M. Wilson, MD, and Shyam Kottilil, MD, PhD, explain in AGA Perspectives that there is mounting evidence that many patients can achieve sustained virologic response with only eight weeks of treatment. The shorter duration therapy substantially reduces treatment costs and may also improve adherence as adherence tends to decrease as therapy duration increases. 

The authors recommend further exploration into shorter HCV therapy in target populations to address some of the issues that may arise, such as optimal retreatment strategies and the emergence of resistance-associated variants. 

Read the full article in AGA Perspectives.

More on Hepatitis C

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Medicaid Skimps on Hepatitis C Treatment in Many States

Feb. 8, 2018

Report finds restrictions based on liver disease severity, sobriety and type of provider.

Image Challenge: Cullen's Sign

Jan. 22, 2018

What caused a 56-year-old man with a previous history of cirrhosis to present with a large volume of ascites and periumbilical ecchymosis?